142 related articles for article (PubMed ID: 31168758)
1. Treatment and survival of Asian women diagnosed with breast cancer in New Zealand.
Lao C; Lawrenson R; Edwards M; Campbell I
Breast Cancer Res Treat; 2019 Sep; 177(2):497-505. PubMed ID: 31168758
[TBL] [Abstract][Full Text] [Related]
2. The impact of different tumour subtypes on management and survival of New Zealand women with Stage I-III breast cancer.
Lawrenson R; Lao C; Campbell I; Harvey V; Seneviratne S; Elwood M; Sarfati D; Kuper-Hommel M
N Z Med J; 2018 May; 131(1475):51-60. PubMed ID: 29771902
[TBL] [Abstract][Full Text] [Related]
3. Treatment and survival disparities by ethnicity in New Zealand women with stage I-III breast cancer tumour subtypes.
Lawrenson R; Lao C; Campbell I; Harvey V; Seneviratne S; Edwards M; Elwood M; Scott N; Kidd J; Sarfati D; Kuper-Hommel M
Cancer Causes Control; 2017 Dec; 28(12):1417-1427. PubMed ID: 29027594
[TBL] [Abstract][Full Text] [Related]
4. Metastatic relapse of stage I-III breast cancer in New Zealand.
Lao C; Kuper-Hommel M; Elwood M; Campbell I; Lawrenson R
Cancer Causes Control; 2021 Jul; 32(7):753-761. PubMed ID: 33830387
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer biology and ethnic disparities in breast cancer mortality in new zealand: a cohort study.
Seneviratne S; Lawrenson R; Scott N; Kim B; Shirley R; Campbell I
PLoS One; 2015; 10(4):e0123523. PubMed ID: 25849101
[TBL] [Abstract][Full Text] [Related]
6. Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study.
Seneviratne S; Campbell I; Scott N; Kuper-Hommel M; Round G; Lawrenson R
BMC Cancer; 2014 Nov; 14():839. PubMed ID: 25406582
[TBL] [Abstract][Full Text] [Related]
7. Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.
Hsieh MC; Zhang L; Wu XC; Davidson MB; Loch M; Chen VW
J Natl Compr Canc Netw; 2019 Jun; 17(6):676-686. PubMed ID: 31200362
[TBL] [Abstract][Full Text] [Related]
8. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Chan A; Delaloge S; Holmes FA; Moy B; Iwata H; Harvey VJ; Robert NJ; Silovski T; Gokmen E; von Minckwitz G; Ejlertsen B; Chia SKL; Mansi J; Barrios CH; Gnant M; Buyse M; Gore I; Smith J; Harker G; Masuda N; Petrakova K; Zotano AG; Iannotti N; Rodriguez G; Tassone P; Wong A; Bryce R; Ye Y; Yao B; Martin M;
Lancet Oncol; 2016 Mar; 17(3):367-377. PubMed ID: 26874901
[TBL] [Abstract][Full Text] [Related]
9. Ethnic differences in breast cancer survival in New Zealand: contributions of differences in screening, treatment, tumor biology, demographics and comorbidities.
Seneviratne S; Campbell I; Scott N; Shirley R; Peni T; Lawrenson R
Cancer Causes Control; 2015 Dec; 26(12):1813-24. PubMed ID: 26407955
[TBL] [Abstract][Full Text] [Related]
10. Associated Factors and Survival Outcomes for Breast Conserving Surgery versus Mastectomy among New Zealand Women with Early-Stage Breast Cancer.
Abrahimi MS; Elwood M; Lawrenson R; Campbell I; Tin Tin S
Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33800387
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of early stage breast cancer in the Auckland and Waikato regions of New Zealand.
Campbell I; Lao C; Blackmore T; Edwards M; Hayes L; Ng A; Lawrenson R
ANZ J Surg; 2018 Dec; 88(12):1263-1268. PubMed ID: 30253442
[TBL] [Abstract][Full Text] [Related]
12. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
[TBL] [Abstract][Full Text] [Related]
13. Mortality impact of less-than-standard therapy in older breast cancer patients.
Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of and differences between Pasifika women and New Zealand European women diagnosed with breast cancer in New Zealand.
Brown C; Lao C; Lawrenson R; Tin Tin S; Schaaf M; Kidd J; Allan-Moetaua A; Herman J; Raamsroop R; Campbell I; Elwood M
N Z Med J; 2017 Dec; 130(1467):50-61. PubMed ID: 29240740
[TBL] [Abstract][Full Text] [Related]
15. The use of trastuzumab in New Zealand women with breast cancer.
Lawrenson R; Lao C; Campbell I; Harvey V; Brown C; Seneviratne S; Edwards M; Elwood M; Kuper-Hommel M
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e152-e160. PubMed ID: 28856817
[TBL] [Abstract][Full Text] [Related]
16. Ethnic disparities in breast cancer survival in New Zealand: which factors contribute?
Tin Tin S; Elwood JM; Brown C; Sarfati D; Campbell I; Scott N; Ramsaroop R; Seneviratne S; Harvey V; Lawrenson R
BMC Cancer; 2018 Jan; 18(1):58. PubMed ID: 29310606
[TBL] [Abstract][Full Text] [Related]
17. Treatment patterns and outcomes in older women with early breast cancer: a population-based cohort study in China.
Liu X; Zheng D; Wu Y; Luo C; Fan Y; Zhong X; Zheng H
BMC Cancer; 2021 Mar; 21(1):226. PubMed ID: 33673816
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
Lambertini M; Ferreira AR; Di Meglio A; Poggio F; Puglisi F; Sottotetti F; Montemurro F; Poletto E; Bernardo A; Risi E; Dellepiane C; Sini V; Minuti G; Grasso D; Fancelli S; Del Mastro L
Clin Breast Cancer; 2017 Dec; 17(8):601-610.e2. PubMed ID: 28479052
[TBL] [Abstract][Full Text] [Related]
19. Use and results of systemic treatments for de novo and recurrent metastatic breast cancer: a population-based cohort study.
Lao C; Kuper-Hommel M; Campbell I; Elwood M; Lawrenson R
N Z Med J; 2021 Nov; 134(1545):47-59. PubMed ID: 34788271
[TBL] [Abstract][Full Text] [Related]
20. Screening status, tumour subtype, and breast cancer survival: a national population-based analysis.
O'Brien KM; Mooney T; Fitzpatrick P; Sharp L
Breast Cancer Res Treat; 2018 Nov; 172(1):133-142. PubMed ID: 30006795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]